纤维细胞激活蛋白:对心力衰竭的核心癌症/化疗洞察力
John Gehris1, Charlie Ervin1, Charlotte Hawkins1
1Cell Biology and Anatomy and Cardiovascular Research Center, University of South Carolina School of Medicine and the Columbia VA Health Care System, Columbia, SC, United States.
纤维细胞激活蛋白 (FAP) 驱动癌症的进展,可能是心力衰竭 (HF) 的目标. 针对高风中的FAP可以通过重新定位癌症治疗来提供新的诊断和治疗策略.
科学领域:
- 心血管研究研究心血管研究
- 在瘤学瘤学.
- 生物化学 生物化学
背景情况:
- 细胞外基质 (ECM) 降解对癌症进展至关重要,涉及癌症相关纤维细胞 (CAF).
- 纤维细胞激活蛋白 (FAP) 在癌症进展和CAF增殖过程中被放大.
- 心力衰竭 (HF) 涉及左心室 (LV) 改造和ECM变化,纤维细胞激活类似于CAFs.
研究的目的:
- 假设涉及癌症的FAP可能是HF的治疗目标.
- 探索FAP向策略的翻译相关性,从瘤学到心脏病学.
主要方法:
- 关于癌症和HF中的FAP科学文献的综述.
- 分析癌症相关纤维细胞和激活的心脏纤维细胞之间的共享机制.
- 对现有的针对FAP的化疗药物进行评估,以评估其潜在的重新用途.
主要成果:
- 在癌症和HF中,FAP在激活的纤维细胞中被上调.
- 激活的心脏纤维细胞与CAF具有功能上的相似性.
- 现有的FAP向剂显示出用于HF治疗的潜力.
结论:
- FAP代表了对HF的有前途的治疗标.
- 重用基于癌症的FAP疗法可能为HF患者提供新的诊断和治疗途径.
更多相关视频
07:17Author Spotlight: Understanding Chronic Lung Diseases Using 3D Printed Phototunable Hydrogels
Published on: June 30, 2023
09:16Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
相关概念视频
Introduction to Fibroblasts
Mitogens and the Cell Cycle
Regulation of Angiogenesis and Blood Supply
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Pathophysiology of Heart Failure
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
